AD
Bydureon(CAS: 141758-74-9)
CAS Number
Related Products
![[3-(2-Hydroxyethyl)phenyl]boronic acid](https://static.chemtradehub.com/structs/647/647853-32-5-c363.webp)
![N-(Butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine hydrochloride hydrate](https://static.chemtradehub.com/structs/150/150915-40-5-1679.webp)
6-(4-methylpiperazin-1-yl)-1H-indole
CAS Number: 321745-04-4
N-Methyl-3-pyrrolidinamine
CAS Number: 83030-08-4
![2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide](https://static.chemtradehub.com/structs/879/879085-55-9-5abe.webp)
3-Nonyne
CAS Number: 20184-89-8
2,2'-(9H-fluorene-9,9-diyl)diethanol
CAS Number: 203070-78-4
![1,4-Dioxaspiro[4.5]dec-8-ylacetic acid](https://static.chemtradehub.com/structs/134/134136-04-2-8def.webp)
Other Suppliers for Bydureon
Basic Information
Molecular Formula
C184H282N50O60S
Molecular Weight
4187 g/mol
Chemical Identifiers
SMILES
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N
InChIKey
HTQBXNHDCUEHJF-XWLPCZSASA-N
Database References
MDL Number
MFCD08704781
FAQ
Bydureon, with the CAS number 141758-74-9, is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily in the treatment of type 2 diabetes. It is a synthetic peptide drug that mimics the action of GLP-1, a hormone involved in regulating blood sugar levels. Bydureon has a molecular formula of C53H77N15O13S and is known for its long-acting properties, administered once weekly.
Bydureon (CAS: 141758-74-9) is mainly used as a medication for managing type 2 diabetes. It helps to increase insulin secretion, reduce glucagon release, and slow gastric emptying, thereby improving blood glucose control. Additionally, it may be used in combination with other diabetes medications to enhance therapeutic outcomes. Its applications also extend to research in metabolic disorders and drug development.
Bydureon (CAS: 141758-74-9) is generally considered safe when used as directed. It is approved by the FDA for its therapeutic use in type 2 diabetes. However, like all medications, it may cause side effects such as nausea, vomiting, or hypoglycemia. Proper handling and administration under medical supervision are essential to ensure safety and minimize risks.
Bydureon (CAS: 141758-74-9) should be stored in a cool, dry place away from direct light. It is typically kept at room temperature (15°C to 25°C) and protected from moisture. The medication should be stored in its original container to maintain stability and prevent degradation. Always check the expiration date and follow the manufacturer's guidelines for storage conditions.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Miss Xu
1986399151@qq.com
Mobile
15221998634
Telephone
021-59178156
Visit Website
https://www.yingxinbio.com/Address
Yugang Town Yiling Road 258 Lane C Zone